MENU

David Y.T. Chen, MD, FACS

Dr. Chen

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

Associate Professor

Director, Urologic Oncology Fellowship Program 

Treatment Focus

Urinary Diversions, Minimally Invasive Surgical Techniques - Laparoscopic, Robotic Surgery, Robotic Surgery and Urologic cancer ablation therapy (cryosurgery or HIFU)

Research Program

Treatment Philosophy

I am a urologic oncologist specializing in surgical treatment of cancers of the genitourinary tract. I have extensive experience with laparoscopic and minimally invasive surgical techniques and apply these approaches routinely to reduce the pain, recovery time, and complications associated with traditional open surgery.

I am skilled in nerve-sparing and organ-reconstructive surgery essential for preserving normal functions when treating prostate, testis, bladder and kidney cancer. I am sensitive to the particular issues regarding the diagnosis of genitourinary cancer and its subsequent treatment, including its physical and emotional effects on the patient and their family and support system.

I recognize each person is unique and requires a treatment individually tailored to them to achieve successful cancer treatment, limited treatment-related side effects and maintained quality of life.

Follow on Twitter: @dytcmd

Educational Background

  • Fellow, Howard Hughes Medical Institute-National Institutes of Health Research Scholar, Bethesda, MD
  • Fellow, Urologic Oncology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
  • Resident, Urology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
  • MD, Cornell University Medical College, 1997, New York, NY

     

Certifications

  • American College of Surgeons
  • The American Board of Urology

Memberships

  • The Society of Laparoendoscopic Surgeons
  •  American Urological Association
  • Philadelphia Urological Society
  • Eastern Cooperative Oncology Group (ECOG)
  • Society of Urologic Oncology

Honors & Awards

  • Philadelphia Magazine Top Docs, 2011-2015

Larry Griffin

Prostate Cancer

Larry Griffin

Prostate Cancer

In December 2009, after monitoring his PSA levels for about four years, Larry Griffin’s doctor recommended that he have a prostate biopsy. “When the results were available, my doctor explained that traces of cancer were identified in four of the 12 tissue samples,” remembers Larry, who had no symptoms. Although he felt healthy and was active, Larry, who was 57, turned to friends and family for support and guidance to deal with his prostate cancer diagnosis.

Antonio Pereira

Kidney Cancer

Antonio Pereira

Kidney Cancer

Antonio Pereira always had an annual physical with his doctor, whom doctor he trusted and respected. In 2005, when Antonio was 46, a spot appeared during a routine imaging test and his doctor referred him gastroenterologist for further evaluation. “The GI doctor performed a CAT Scan and some other tests and confirmed there was a growth on my left kidney,” recalls Antonio, who had an MRI and was referred to a urologist. “The urologist confirmed what the other two doctors said and I was scheduled for surgery.”

Carlos Perez

Prostate Cancer

Carlos Perez

Prostate Cancer

After watching his father undergo prostate cancer treatment, and later lose his life to stomach cancer, Carlos Perez knew that he was at increased risk of developing cancer himself. "That is why I started to have my PSA levels checked from the time I was in my early 40s," he explained. For many years, Carlos was told that his levels were in the normal range.

Marlene Owens

Kidney Cancer

Marlene Owens

Kidney Cancer

Marlene Owens has always been committed to staying well. She visited her gynecologist yearly and during an annual exam in 2014, when she was 61, her doctor noted that Marlene's uterine lining seemed unusually thick. Marlene underwent a dilation and curettage procedure, often called a D&C, to remove tissue from inside the uterus. This tissue is studied by a pathologist to diagnose uterine conditions, including heavy bleeding. 

John O'Donnell

Prostate Cancer

John O'Donnell

Prostate Cancer

Prior to 2004, John O'Donnell did not regularly visit his doctor for routine check-ups. He was active and felt healthy and didn't see any reason to go to the doctor. But a life insurance blood test indicated high cholesterol, which resulted in a rate increase. That prompted John to see a doctor annually. In the spring of 2009, during a routine appointment, John's doctor noticed something suspicious which raised his concern for prostate cancer. As a result, he sent John for further testing.  

Pages

Selected Publications

Martin JM, Handorf EA, Price RA, Cherian G, Buyyounouski MK, et al. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2015; 40(3):186-9. NIHMSID: NIHMS656177 PubMed

Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy. Corcoran AT, Kaffenberger SD, Clark PE, Walton J, Handorf E, et al. BJU international. 2015; 116(3):351-7. PubMed 

Additional Publications

My NCBI